NCT00036283View on ClinicalTrials.gov

Chemoprevention of Oral Premalignant Lesions

PHASE2CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

November 30, 2000

Study Completion Date

April 30, 2004

Conditions
Precancerous Conditions
Interventions
DRUG

Celecoxib

Trial Locations (7)

48109

Pfizer Investigational Site, Ann Arbor

55455

Pfizer Investigational Site, Minneapolis

71103

Pfizer Investigational Site, Shreveport

77030

Pfizer Investigational Site, Houston

06030-3805

Pfizer Investigational Site, Farmington

Unknown

Pfizer Investigational Site, New York

98195-6607

Pfizer Investigational Site, Seattle

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT00036283 - Chemoprevention of Oral Premalignant Lesions | Biotech Hunter | Biotech Hunter